148 related articles for article (PubMed ID: 29515275)
1. Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
Kadakol A; Malek V; Goru SK; Pandey A; Gaikwad AB
Indian J Pharmacol; 2017; 49(5):348-356. PubMed ID: 29515275
[TBL] [Abstract][Full Text] [Related]
2. Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
Kadakol A; Pandey A; Goru SK; Malek V; Gaikwad AB
Eur J Pharmacol; 2015 Oct; 765():591-7. PubMed ID: 26409041
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
Malek V; Gaikwad AB
Cardiovasc Res; 2019 Feb; 115(2):373-384. PubMed ID: 30184174
[TBL] [Abstract][Full Text] [Related]
4. Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.
Kadakol A; Goru SK; Malek V; Gaikwad AB
Biomed Pharmacother; 2017 Nov; 95():1461-1468. PubMed ID: 28946194
[TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
Guo Z; Zheng C; Qin Z; Wei P
J Pharm Pharmacol; 2011 Jan; 63(1):87-94. PubMed ID: 21155820
[TBL] [Abstract][Full Text] [Related]
6. The effects of telmisartan on mechanical responses of left ventricular papillary muscle in rats with streptozotocin-induced diabetes mellitus.
Emre M; Kavak S; Unlugenc H
Acta Diabetol; 2010 Dec; 47 Suppl 1():153-9. PubMed ID: 19855921
[TBL] [Abstract][Full Text] [Related]
7. Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis.
Pandey A; Gaikwad AB
Biochem Biophys Res Commun; 2017 Jun; 487(4):827-833. PubMed ID: 28456626
[TBL] [Abstract][Full Text] [Related]
8. H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.
Pandey A; Goru SK; Kadakol A; Malek V; Sharma N; Gaikwad AB
Biochimie; 2016 Dec; 131():68-76. PubMed ID: 27693081
[TBL] [Abstract][Full Text] [Related]
9. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
Du GT; Hu M; Mei ZL; Wang C; Liu GJ; Hu M; Long Y; Miao MX; Chang Li J; Hong H
J Pharmacol Sci; 2014; 124(4):418-26. PubMed ID: 24671053
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
13. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
Surse VM; Gupta J; Tikoo K
J Mol Endocrinol; 2011 Jun; 46(3):245-54. PubMed ID: 21450970
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Chang WT; Cheng JT; Chen ZC
Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
[TBL] [Abstract][Full Text] [Related]
16. Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats.
Guo Z; Zhang R; Li J; Xu G
Cardiovasc Diabetol; 2012 Aug; 11():94. PubMed ID: 22873349
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats.
Ola MS; Ahmed MM; Abuohashish HM; Al-Rejaie SS; Alhomida AS
Neurochem Res; 2013 Aug; 38(8):1572-9. PubMed ID: 23624827
[TBL] [Abstract][Full Text] [Related]
18. Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats.
Goyal BR; Parmar K; Goyal RK; Mehta AA
Pharmacol Rep; 2011; 63(4):956-66. PubMed ID: 22001983
[TBL] [Abstract][Full Text] [Related]
19. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
Chaudagar KK; Mehta AA
Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
[TBL] [Abstract][Full Text] [Related]
20. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats.
Goyal BR; Mesariya P; Goyal RK; Mehta AA
Mol Cell Biochem; 2008 Jul; 314(1-2):123-31. PubMed ID: 18425420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
